Navigation Links
AMT Receives EMEA Orphan Drug Designation for Acute Intermittent Porphyria
Date:5/27/2009

AMSTERDAM, May 28 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that the European Medicines Agency has granted Orphan Drug Designation to AMT's gene therapy product AMT-021 for the treatment of acute intermittent porphyria (AIP).

Orphan Drug Designation for AIP entitles AMT to ten year market exclusivity in Europe following marketing approval for AMT-021 if this product candidate is the first new drug with a major medical benefit receiving marketing approval for the European Union. The designation also provides for special benefits, including research support, eligibility for protocol assistance and possible exemptions or reductions in certain regulatory fees during development or at the time of application for marketing approval.

"We are proud to have received this Orphan Drug Designation for the treatment of acute intermittent porphyria," said Sander van Deventer, Chief Executive Officer of AMT. "This designation is an important step in the development of a treatment for this seriously debilitating and potentially lethal disease."

About Acute Intermittent Porphyria

Acute intermittent porphyria is a rare genetic disease in which mutations in the PBGD gene result in insufficient activity of a protein necessary for the synthesis of heme. This leads to an accumulation of toxic intermediate metabolites resulting in a wide variety of problems including acute, severe abdominal pains, psychiatric, neurologic illnesses, and muscular weakness. Long-term consequences may be irreversible nerve damage, liver cancer and kidney failure. Acute porphyric attacks can be life-threatening.

AIP affects 1 per 10.000 people in the European Union.

Currently available therapies do not prevent the symptoms and consequences of acute porphyric attacks. AMT has demonstrated that its prod
'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
5. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
6. CryoCor Receives FDA Approval for Right Atrial Flutter
7. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
8. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
9. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
10. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
11. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Calif. , July 10, 2014  Breg, ... and services, has launched the FreeRunner™ knee brace ... who suffer from patella mal-tracking return to active ... differently than other braces, providing support when patients ... normally when they don,t. Patellofemoral issues ...
(Date:7/10/2014)... Pa. , July 10, 2014 ... Moberg Research,s (Moberg) medical device manufacturing facility. Rep. ... Moberg,s advanced neurological monitors facilitate cutting-edge research in ... Rep. Kennedy and mental health advocate, Garen ... organization dedicated to fostering fundamental changes that will ...
(Date:7/10/2014)... , July 10, 2014   Ventana Medical Systems, ... announced it has entered into an agreement with Merck ... as EMD Serono in the United States ... collaborate with Merck KGaA,s biopharmaceutical division on the development ... undisclosed target using Ventana,s proprietary diagnostic assays. In alignment ...
Breaking Medicine Technology:Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2Representative Patrick Kennedy visits Moberg's medical device facility to discuss improvement in brain injury care 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3
... Data to be presented November 2 at the American Society of Nephrology ... ... Calif., Oct. 16 ,Exelixis, Inc. (Nasdaq: EXEL ) announced that a ... of reducing proteinuria,compared with placebo in patients with proteinuria associated with diabetic,nephropathy. ...
... Concentra, the largest,occupational health care provider with ... to educate America,s workforce about the flu, how ... The company expects to vaccinate,nearly 300,000 people across ... lost productivity. Concentra Medical Centers offers flu ...
Cached Medicine Technology:Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy 2Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy 3Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy 4Concentra Offers Flu Vaccines to Keep America Working 2
(Date:7/12/2014)... (PRWEB) July 12, 2014 “After my mom’s stroke, ... had a stroke and loss the use of his left side. ... design a way to help people like them enjoy eating again,” ... a prototype for the PATRICIA CAROL HALL PLATE (P C H ... offers a more ergonomic way to eat for individuals who suffer ...
(Date:7/12/2014)... July 12, 2014 Wright & Schulte LLC ... Orthopedics , Inc., a subsidiary of Johnson & Johnson, on ... chronic pain after receiving a metal-on-metal DePuy Pinnacle hip replacement ... remove the artificial hip implant. The DePuy hip lawsuit was ... District of Texas (Case No. 3:14-cv-2427) where DePuy Pinnacle ...
(Date:7/12/2014)... 2014 Dubai is buzzing with the ... heading to the UAE. The National Basketball Association’s ... in the UAE from 28-31 October to lead the ... diabetes awareness. The event is being organized by Maven ... management company based in Dubai. The announcement was made ...
(Date:7/12/2014)... 12, 2014 Floor-grade instrument ... 4.1 out of 5. This above-average score represents ... underpinning buyer negotiation power over the three years ... Son, “during the period, surging demand for healthcare ... with new product development, have placed upward pressure ...
(Date:7/11/2014)... Recently, DressyQuinceanera.com, a well-known wedding dress manufacturer and retailer, ... its online category. Furthermore, the firm has announced that ... up to 62% off. , The brand new Quinceanera ... of quality and style. All items in the new ... for the company’s other items: lace evening dresses, short ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 3Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 5Health News:Los Angeles Basketball Legend Headed to Dubai 2Health News:Los Angeles Basketball Legend Headed to Dubai 3Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:DressyQuinceanera.com: Beautiful Quinceanera Dama Dresses At Low Prices 2
... Nov. 8 Synova Healthcare Group,Inc. (OTC Bulletin Board: ... its Today(R) Sponge non-hormonal contraceptive,product in Hong Kong and ... Hong Kong. This represents an important milestone for the,Company, ... made the Today(R) Sponge,available to women outside North America. ...
... Nov. 8, 2007 An Israeli-Jordanian-U.S. cooperative project aimed ... neighboring southern cities of Aqaba in Jordan and Eilat ... Hebrew University of Jerusalem together with scientists from the ... Research Institute of Reno, Nevada, in the US. ...
... determined how cardiac cells die just as emergency treatments restore blood ... puzzled doctors who are able to relieve pain in patients suffering ... renewed rush of blood. , The discovery may lead to ... the stoppage of blood flow and resulting loss of oxygen to ...
... , The topic of cancer prevention is covered ... with apparently conflicting information and complex scientific research that ... The American Association for Cancer Research (AACR) and Susan ... communication between the scientific research community and journalists who ...
... New Law and New Regulations Could Hold the Key to ... Reducing Rising Skin Cancer Rates, NEW YORK, ... of skin cancer will be diagnosed in the United States in,2007. While ... stress that prevention is still the best,medicine. In fact, dermatologists are hopeful ...
... NEW YORK, Nov. 8 The changing of the ... to health clubs for a,healthy dose of indoor exercise. ... beneficial activities a person can do to improve one,s ... the hidden dangers of,exercise -- bothersome skin conditions that ...
Cached Medicine News:Health News:Today(R) Sponge to be Distributed in Hong Kong and Macau 2Health News:Today(R) Sponge to be Distributed in Hong Kong and Macau 3Health News:'Beam of Light' is ray of hope for Israeli-Jordanian cooperation 2Health News:Mitochondria send death signal to cardiac cells, study shows 2Health News:Mitochondria send death signal to cardiac cells, study shows 3Health News:Skin Cancer Prevention Update: 2Health News:Skin Cancer Prevention Update: 3Health News:Skin Cancer Prevention Update: 4Health News:Skin Cancer Prevention Update: 5Health News:Dermatologists Warn Fitness Enthusiasts: Don't Let Exercise-Related Skin Problems Outweigh the Benefits of Physical Activity 2Health News:Dermatologists Warn Fitness Enthusiasts: Don't Let Exercise-Related Skin Problems Outweigh the Benefits of Physical Activity 3Health News:Dermatologists Warn Fitness Enthusiasts: Don't Let Exercise-Related Skin Problems Outweigh the Benefits of Physical Activity 4Health News:Dermatologists Warn Fitness Enthusiasts: Don't Let Exercise-Related Skin Problems Outweigh the Benefits of Physical Activity 5
... Combining exceptional new features ... XLTEKs latest innovation, the ... biphasic intracranial stimulation up ... 300 volts and transcranial ...
... high-volume analyzer that builds upon the field-proven ... and the latest Olympus technological advances. The ... with up to 147 on-board chemistries and ... Choose from Olympus 122 test menu, including ...
... e is designed for the ... laboratories and hospitals. Automate and consolidate ... reliability and Olympus 122 test menu, ... specific proteins, esoteric chemistries and tests ...
... is intended for the quantitative determination of Erythropoietin ... for in vitro diagnostic use, as an aid ... the advent of the administration of recombinant erythropoietin ... cell mass, an erythropoietin assay may be used ...
Medicine Products: